Xponance, Inc. Durect Corp Put Options Transaction History
Xponance, Inc.
- $10.2 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DRRX
# of Institutions
3Shares Held
593KCall Options Held
0Put Options Held
0About DURECT CORP
- Ticker DRRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 227,794,000
- Market Cap $230M
- Description
- DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...